Atlas FDA

TRUFILL n-BCA Liquid Embolic System (LES), TRUFILL n-BCA Liquid Embolic System Procedural Set

FDA premarket approval P990040/S034 · decided 2025-12-16

Approval details

PMA number
P990040
Supplement
S034
Supplement type
Panel Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
TRUFILL n-BCA Liquid Embolic System (LES), TRUFILL n-BCA Liquid Embolic System Procedural Set
Generic name
Neurovascular Liquid Embolic Agent
Applicant
Cerenovus, Inc.
Date received
2025-02-03
Decision date
2025-12-16
Days to decision
316 days
Decision code
APPR
Product code
SGU
Advisory committee
Neurology
Expedited review
No
Location
Miami, FL
Statement
The TRUFILL n-BCA Liquid Embolic System is indicated for the embolization of cerebral arteriovenous malformations (AVMs) when pre-surgical devascularization is desired and for embolization of the Middle Meningeal Artery (MMA) for the treatment of symptomatic subacute and chronic Subdural Hematoma (SDH) as an adjunct to surgery.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
CEREGLIDE 71 Catheter System; Cerenovus Aspiration Tubing Set (K251828)Cerenovus, Inc.2025-08-22
CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 Intermediate Catheter; Cerenovus Aspiration Tubing Set (K241221)Cerenovus, Inc.2024-10-16
CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 Intermediate Catheter (K241244)Cerenovus, Inc.2024-10-16
CEREGLIDE 92 Catheter System (K233982)Cerenovus, Inc.2024-05-09
Cerenovus Large Bore Catheter; Cerenovus Aspiration Tubing Set (K233988)Cerenovus, Inc.2024-01-17
CEREGLIDE 92 Intermediate Catheter (K230726)Cerenovus, Inc.2023-11-29
CEREGLIDE 71 Intermediate Catheter; Cerenovus Aspiration Tubing Set (K221934)Cerenovus, Inc.2023-03-09
CEREGLIDE 71 Intermediate Catheter (K221930)Cerenovus, Inc.2023-03-09